Predicting the response to therapy of inflammatory bowel disease with infrared spectroscopy
Recruiting
- Conditions
- K51K50Ulcerative colitisCrohn disease [regional enteritis]
- Registration Number
- DRKS00033130
- Lead Sponsor
- niversitätsklinikum Erlangen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1500
Inclusion Criteria
established diagnosis of ulcerative colitis or Crohn's disease
- diagnostic ileocolonoscopy with biopsies and subsequent initiation of a novel anti-inflammatory therapy
Exclusion Criteria
- drugs, concomitant diseases or conditions that preclude the assessment of clinical response/remission
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical remission week 16
- Secondary Outcome Measures
Name Time Method Clinical remission week 52<br>Endoscopic remission week 52<br>Steroid-free remission week 52